Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812 · clinicaltrials.gov ↗
RECRUITING
Status
3500
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Collaborators